P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE

Cardiovascular diseases are substantial causes of mortality among patients with chronic kidney disease (CKD). The aim of the study was an assessment of the impact of cardiovascular risk factors on left ventricular hypertrophy (LVH) in children with CKD. Material and methods: The study was conducted...

Full description

Bibliographic Details
Main Authors: Dorota Drozdz*, Przemko Kwinta, Zbigniew Kordon, Katarzyna Zachwieja, Monika Miklaszewska, Krystyna Sztefko, Andrzej Rudzinski, Jacek Antoni Pietrzyk
Format: Article
Language:English
Published: BMC 2015-11-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125930617/view
_version_ 1818230405315166208
author Dorota Drozdz*
Przemko Kwinta
Zbigniew Kordon
Katarzyna Zachwieja
Monika Miklaszewska
Krystyna Sztefko
Andrzej Rudzinski
Jacek Antoni Pietrzyk
author_facet Dorota Drozdz*
Przemko Kwinta
Zbigniew Kordon
Katarzyna Zachwieja
Monika Miklaszewska
Krystyna Sztefko
Andrzej Rudzinski
Jacek Antoni Pietrzyk
author_sort Dorota Drozdz*
collection DOAJ
description Cardiovascular diseases are substantial causes of mortality among patients with chronic kidney disease (CKD). The aim of the study was an assessment of the impact of cardiovascular risk factors on left ventricular hypertrophy (LVH) in children with CKD. Material and methods: The study was conducted in a group of 71 children with mean age 11 years and CKD stage 1 to 5. Serum cystatin C, albumin levels, and lipids profile were measured. Ambulatory blood pressure measurements and echocardiography were performed. Results: LVH was detected in 34 out of 71 children. In children with LVH, significantly higher values of BP were observed in 24-hour measurements: systolic (119 vs. 109 mm Hg; p=0.002), diastolic BP (73 vs. 65 mm Hg; p=0.009) and MAP (89 vs. 81 mm Hg, p=0.004). These significantly higher BP values were observed within day and night. Increased cholesterol level was found in 25, LDL in 12, TGL in 28, and a decreased HDL in 20 children. In children with LVH higher BMI (18.6 vs. 16.7 kg/m2;p=0.039) and lower albumin (41.5 vs. 45.4 g/l; p=0.013), HDL (1.14 vs. 1.5 mmol/l; p=0.001) and Ca levels (2.36 vs. 2.47 mmol/l; p=0.03) were found. Obesity and low HDL level were independent LVH risk factors. The results indicate a 3-fold increase in the risk of LVH in children with hypertension (OR 3.18, p=0.045), rising up when 2-3 risk factors were present (OR 6, p=0.015). Conclusions: Hypertension, a decreased HDL cholesterol level and overhydration have significant impact on the development of LVH in CKD children.
first_indexed 2024-12-12T10:33:58Z
format Article
id doaj.art-d0739179b9c6411e802c7ed2cb0e60e8
institution Directory Open Access Journal
issn 1876-4401
language English
last_indexed 2024-12-12T10:33:58Z
publishDate 2015-11-01
publisher BMC
record_format Article
series Artery Research
spelling doaj.art-d0739179b9c6411e802c7ed2cb0e60e82022-12-22T00:27:16ZengBMCArtery Research1876-44012015-11-011210.1016/j.artres.2015.10.263P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASEDorota Drozdz*Przemko KwintaZbigniew KordonKatarzyna ZachwiejaMonika MiklaszewskaKrystyna SztefkoAndrzej RudzinskiJacek Antoni PietrzykCardiovascular diseases are substantial causes of mortality among patients with chronic kidney disease (CKD). The aim of the study was an assessment of the impact of cardiovascular risk factors on left ventricular hypertrophy (LVH) in children with CKD. Material and methods: The study was conducted in a group of 71 children with mean age 11 years and CKD stage 1 to 5. Serum cystatin C, albumin levels, and lipids profile were measured. Ambulatory blood pressure measurements and echocardiography were performed. Results: LVH was detected in 34 out of 71 children. In children with LVH, significantly higher values of BP were observed in 24-hour measurements: systolic (119 vs. 109 mm Hg; p=0.002), diastolic BP (73 vs. 65 mm Hg; p=0.009) and MAP (89 vs. 81 mm Hg, p=0.004). These significantly higher BP values were observed within day and night. Increased cholesterol level was found in 25, LDL in 12, TGL in 28, and a decreased HDL in 20 children. In children with LVH higher BMI (18.6 vs. 16.7 kg/m2;p=0.039) and lower albumin (41.5 vs. 45.4 g/l; p=0.013), HDL (1.14 vs. 1.5 mmol/l; p=0.001) and Ca levels (2.36 vs. 2.47 mmol/l; p=0.03) were found. Obesity and low HDL level were independent LVH risk factors. The results indicate a 3-fold increase in the risk of LVH in children with hypertension (OR 3.18, p=0.045), rising up when 2-3 risk factors were present (OR 6, p=0.015). Conclusions: Hypertension, a decreased HDL cholesterol level and overhydration have significant impact on the development of LVH in CKD children.https://www.atlantis-press.com/article/125930617/view
spellingShingle Dorota Drozdz*
Przemko Kwinta
Zbigniew Kordon
Katarzyna Zachwieja
Monika Miklaszewska
Krystyna Sztefko
Andrzej Rudzinski
Jacek Antoni Pietrzyk
P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
Artery Research
title P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
title_full P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
title_fullStr P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
title_full_unstemmed P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
title_short P4.19 CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
title_sort p4 19 cardiovascular risk factors and left ventricular hypertrophy in children with chronic kidney disease
url https://www.atlantis-press.com/article/125930617/view
work_keys_str_mv AT dorotadrozdz p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease
AT przemkokwinta p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease
AT zbigniewkordon p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease
AT katarzynazachwieja p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease
AT monikamiklaszewska p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease
AT krystynasztefko p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease
AT andrzejrudzinski p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease
AT jacekantonipietrzyk p419cardiovascularriskfactorsandleftventricularhypertrophyinchildrenwithchronickidneydisease